ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,374Medicare Part D Prescriptions Filled, Including Refills

Rank: 492 out of 3001

$321K Total Retail Price of All Prescriptions

Rank: 1291 out of 3001

415 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 415 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,376 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LOVASTATIN 535 499 1 38
LISINOPRIL 487 459 2 2
SIMVASTATIN 296 271 3 1
FUROSEMIDE 269 265 4 6
LEVOTHYROXINE SODIUM 254 228 5 3
METFORMIN HCL 250 235 6 9
OMEPRAZOLE 249 203 7 4
HYDROCHLOROTHIAZIDE 237 233 8 10
ATENOLOL 204 176 9 18
LOSARTAN POTASSIUM 197 194 10 21
AMLODIPINE BESYLATE 195 192 11 5
DONEPEZIL HCL 178 168 12 27
PRAVASTATIN SODIUM 176 155 13 13
DOXAZOSIN MESYLATE 174 162 14 90
ENALAPRIL MALEATE 174 162 14 83
WARFARIN SODIUM 152 114 16 12
POTASSIUM CHLORIDE 149 121 17 15
GABAPENTIN 148 148 18 14
METOPROLOL TARTRATE 126 122 19 8
TRAZODONE HCL 124 95 20 37
SERTRALINE HCL 118 94 21 20
FLUTICASONE PROPIONATE 117 99 22 42
HYDROCODONE-ACETAMINOPHEN 116 74 S3 23 7
ATORVASTATIN CALCIUM 113 108 24 11
CITALOPRAM HBR 108 108 25 16
ALLOPURINOL 108 96 25 35
GLYBURIDE 108 101 R 25 62
RANITIDINE HCL 104 98 28 41
PREDNISONE 90 82 29 39
PROAIR HFA 89 72 30 30
NAMENDA 88 88 31 40
KLOR-CON 10 84 84 32 160
AZITHROMYCIN 83 69 33 36
ALENDRONATE SODIUM 76 75 34 26
DILTIAZEM 24HR ER 73 65 35 131
CARVEDILOL 71 71 36 25
VERAPAMIL ER 70 60 37 102
TAMSULOSIN HCL 69 62 38 29
CYCLOBENZAPRINE HCL 67 40 R 39 73
PANTOPRAZOLE SODIUM 60 57 40 43
FLUOXETINE HCL 60 39 40 61
NIFEDIPINE ER 59 59 42 154
BENAZEPRIL HCL 56 56 43 123
TERAZOSIN HCL 55 55 44 135
METOPROLOL SUCCINATE 53 41 45 19
TRIAMTERENE-HCTZ 51 41 46 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.